Xenetic Biosciences, Inc.
XBIO
$2.72
-$0.1006-3.57%
NASDAQ
| 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | |
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | -34.51% | -34.00% | -31.36% | -30.04% | -31.95% |
| Total Receivables | -- | -- | -- | -- | -- |
| Inventory | -- | -- | -- | -- | -- |
| Prepaid Expenses | -61.95% | -24.58% | 279.58% | -50.07% | 54.03% |
| Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
| Other Current Assets | 173.44% | -69.43% | -94.40% | -96.00% | -86.34% |
| Total Current Assets | -33.20% | -34.60% | -31.29% | -37.57% | -33.46% |
|
|
|||||
| Total Current Assets | -33.20% | -34.60% | -31.29% | -37.57% | -33.46% |
| Net Property, Plant & Equipment | -- | -- | -- | -- | -- |
| Long-term Investments | -- | -- | -- | -- | -- |
| Goodwill | -- | -- | -- | -- | -- |
| Total Other Intangibles | -- | -- | -- | -- | -- |
| Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
| Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
| Total Other Assets | -- | -69.18% | -69.18% | 44.58% | 44.58% |
| Total Assets | -40.73% | -38.35% | -34.92% | -32.73% | -29.15% |
|
|
|||||
| Total Accounts Payable | 3.95% | 14.16% | 17.77% | -45.76% | 28.15% |
| Total Accrued Expenses | -59.62% | -15.49% | 7.35% | 23.58% | 100.62% |
| Short-term Debt | -- | -- | -- | -- | -- |
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Current Liabilities | -- | -- | -- | -- | -- |
| Total Current Liabilities | -43.10% | -6.78% | 10.46% | -5.53% | 82.21% |
|
|
|||||
| Total Current Liabilities | -43.10% | -6.78% | 10.46% | -5.53% | 82.21% |
| Long-Term Debt | -- | -- | -- | -- | -- |
| Short-term Debt | -- | -- | -- | -- | -- |
| Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Non Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Liabilities | -- | -- | -- | -- | -- |
| Total Liabilities | -43.10% | -6.78% | 10.46% | -5.53% | 82.21% |
|
|
|||||
| Common Stock & APIC | 0.04% | 0.05% | 0.08% | 0.11% | 0.13% |
| Retained Earnings | -1.58% | -1.89% | -2.05% | -2.12% | -2.46% |
| Treasury Stock & Other | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| Total Common Equity | -40.24% | -40.97% | -38.68% | -35.40% | -37.32% |
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Convertible | 0.00% | 0.00% | 0.00% | -35.71% | -35.71% |
| Preferred Stock, Others | -- | -- | -- | -- | -- |
| Total Preferred Equity | 0.00% | 0.00% | 0.00% | -35.71% | -35.71% |
|
|
|||||
| Total Common Equity | -40.24% | -40.97% | -38.68% | -35.40% | -37.32% |
| Total Preferred Equity | 0.00% | 0.00% | 0.00% | -35.71% | -35.71% |
| Total Minority Interest | -- | -- | -- | -- | -- |
| Total Equity | -40.23% | -40.96% | -38.67% | -35.40% | -37.31% |
|
|
|||||